We included individuals older than 30 years of age with a diagnosis of hypertension who received first‐line medications for hypertension, which included three classes: angiotensin‐converting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARB), and dihydropyridine calcium channel blockers (dCCB). This evidence concerns the gene ACE and Hypertension.